Relief Therapeutics' Wholly Owned Subsidiary, APR Applied Pharma Research, Reports Final Data from Its Clinical Trial of Novel Nasal Spray, Sentinox, in SARS-CoV-2 Infected Patients
Relief Therapeutics Holding SA / Key word(s): Study results Relief Therapeutics Wholly Owned Subsidiary, APR Applied Pharma Research, Reports...
Giancarlo Icardi Michael Miller Jack Weinstein Advita Lifescience Gmb Relief Therapeutics Holding Pharma Research
Source: businessinsider.com